RELAPSED AND REFRACTORY CD5 HEMATOLOGICAL TUMORS

Clinical trials for RELAPSED AND REFRACTORY CD5 HEMATOLOGICAL TUMORS explained in plain language.

Never miss a new study

Get alerted when new RELAPSED AND REFRACTORY CD5 HEMATOLOGICAL TUMORS trials appear

Sign up with your email to follow new studies for RELAPSED AND REFRACTORY CD5 HEMATOLOGICAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 'Living Drug' trial targets tough blood cancers

Disease control Recruiting now

This early-stage study is testing the safety and finding the right dose of a new experimental treatment called CD5CART for adults with advanced blood cancers that have returned or stopped responding to standard therapies. The treatment involves collecting a patient's own immune c…

Matched conditions: RELAPSED AND REFRACTORY CD5 HEMATOLOGICAL TUMORS

Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Apr 01, 2026 23:11 UTC

RELAPSED AND REFRACTORY CD5 HEMATOLOGICAL TUMORS

Get alerted when new RELAPSED AND REFRACTORY CD5 HEMATOLOGICAL TUMORS trials appear

New 'Living Drug' trial targets tough blood cancers